US 7422867
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
granted A61KA61K38/1709
Quick answer
US patent 7422867 (Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein) held by Rigel Pharmaceuticals, Inc. expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/1709